JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bromley, B.
Right arrow Articles by Benacerraf, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bromley, B.
Right arrow Articles by Benacerraf, B. R.
© 2002 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 21:1387-1394 • 0278-4297

Fetal Nose Bone Length

A Marker for Down Syndrome in the Second Trimester

Bryann Bromley, MD, Ellice Lieberman, MD, DrPH, Thomas D. Shipp, MD and Beryl R. Benacerraf, MD

Departments of Obstetrics and Gynecology and Radiology, Massachusetts General Hospital, and Brigham and Women’s Hospital, Harvard Medical School, Boston Massachusetts. Revised July 10, 2002. Revised manuscript accepted for publication August 1, 2002. Revision requested July 10, 2002. Revised manuscript accepted for publi-cation August 1, 2002.

Address correspondence and reprint requests to Bryann Bromley, MD, Diagnostic Ultrasound Associates, 333 Longwood Ave, Boston, Massachusetts, 02115.

Objective. To evaluate the significance of nasal bone length in relation to the detection of Down syndrome in the second trimester. Methods. We evaluated consecutive fetuses referred to our facility between 15 and 20 weeks’ gestation for sonography and amniocentesis because of an increased risk of aneuploidy. A detailed structural survey, biometric measurements, and measurement of the nasal bone were obtained at the time of amniocentesis and subsequently compared with karyotype. The characteristics of the fetuses with Down syndrome were compared with those of the euploid fetuses. Results. A total of 239 fetuses were evaluated. Sixteen fetuses (7%) had Down syndrome, and 223 were euploid. In fetuses with Down syndrome, 6 (37%) of 16 did not have detectable nose bones, compared with 1 (0.5%) of 223 control fetuses, yielding a likelihood ratio of 83. Detectable nasal bones were seen in 10 fetuses with Down syndrome and 222 euploid fetuses. A receiver operating characteristic curve for the biparietal diameter–nasal bone length ratio showed that a value of 9 or greater detected 100% of fetuses with Down syndrome and 22% of euploid fetuses. If the ratio were 10 or greater, then 81% fetuses with Down syndrome and 11% of euploid fetuses would have been identified. If the ratio were 11 or greater, 69% of fetuses with Down syndrome would be identified, compared with 5% of euploid fetuses. Conclusions. The absence of a nasal bone is a powerful marker for Down syndrome. A short nasal bone is associated with an increased likelihood for fetal Down syndrome in a high-risk population.

Key Words: aneuploidy, second trimester • fetal nose bone length • marker, fetal Down syndrome • midsagittal profile • sonography

Abbreviations: BPD, biparietal diameter • DS, Down syndrome • NBL, nasal bone length • ROC, receiver operating characteristic




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
S. Sutthibenjakul, T. Suntharasaj, C. Suwanrath, O. Kor-anantakul, and A. Geater
A Thai Reference for Normal Fetal Nasal Bone Length at 15 to 23 Weeks' Gestation
J. Ultrasound Med., January 1, 2009; 28(1): 49 - 53.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. O. Odibo, H. M. Sehdev, L. Sproat, C. Parra, L. Odibo, L. Dunn, and G. A. Macones
Evaluating the Efficiency of Using Second-Trimester Nasal Bone Hypoplasia as a Single or a Combined Marker for Fetal Aneuploidy
J. Ultrasound Med., April 1, 2006; 25(4): 437 - 441.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
D. M. Sherer, P. Eugene, M. Dalloul, F. Khoury-Collado, E. Abdelmalek, M. Kheyman, J. A. Osho, and O. Abulafia
Second-trimester diagnosis of cri du chat (5p-) syndrome following sonographic depiction of an absent fetal nasal bone.
J. Ultrasound Med., March 1, 2006; 25(3): 387 - 388.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
C. M. Zelop, E. Milewski, K. Brault, P. Benn, A. F. Borgida, and J. F. X. Egan
Variation of Fetal Nasal Bone Length in Second-Trimester Fetuses According to Race and Ethnicity
J. Ultrasound Med., November 1, 2005; 24(11): 1487 - 1489.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
L. T. Tran, D. B. Carr, L. M. Mitsumori, S. B. Uhrich, and L. E. Shields
Second-Trimester Biparietal Diameter/Nasal Bone Length Ratio Is an Independent Predictor of Trisomy 21
J. Ultrasound Med., June 1, 2005; 24(6): 805 - 810.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
L. F. Goncalves, J. Espinoza, W. Lee, M. L. Schoen, P. Devers, M. Mazor, T. Chaiworapongsa, G. R. DeVore, and R. Romero
Phenotypic Characteristics of Absent and Hypoplastic Nasal Bones in Fetuses With Down Syndrome: Description by 3-Dimensional Ultrasonography and Clinical Significance
J. Ultrasound Med., December 1, 2004; 23(12): 1619 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
W. Cusick, J. Provenzano, C. A. Sullivan, F. M. Gallousis, and J. F. Rodis
Fetal Nasal Bone Length in Euploid and Aneuploid Fetuses Between 11 and 20 Weeks' Gestation: A Prospective Study
J. Ultrasound Med., October 1, 2004; 23(10): 1327 - 1333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Institute of Ultrasound in Medicine.